Mekinist: Precautions and Warnings

Mekinist tablets mainly contain trametinib as an active ingredient. This medication is a MEK inhibitor, which is a sort of targeted therapy called signal transduction inhibitor. It helps resist or block the growth and spread of melanoma cells. 

This medicine is supplied as a form of tablet for oral administration. The recommended daily dose is trametinib 2 mg, should be consumed orally once a day until the disease progression. Consume at least 1 hour prior to or 2 hours following a meal. Do not consume a missed or forgotten dose within 12 hours of the upcoming dose. 

Precautions:

  • Take prescription by a healthcare practitioner before buying trametinib. 
  • You should check that the pharmacy/wholesaler from which you are ordering trametinib is licensed. 
  • Never order trametinib from a wholesaler/pharmacy that does not ask for a prescription letter for making a purchase.
  • In case any discrepancy in the description, never rely on the online wholesaler/pharmacy. 
  • You must check the pharmacy/wholesaler accreditation and reliability. 
  • Do not share trametinib prescription medication with anyone even having the similar problems.
  • Avoid falling for fat discounts, decreased mekinist cost may be given to hook customers. 
  • Never accept trametinib if the packaging is damaged/puffed up.
  • Never accept trametinib if it doesn't look authentic or look tampered with.

Warnings:

  • Retinal pigment epithelial detachments (RPED) may occur while on treatment with trametinib. 
  • Based on its mechanism of action, this medicine can be responsible for causing fetal harm when administered to a pregnant woman. 
  • Hemorrhages may occur when this medicine is used together with the dabrafenib.
  • Venous thromboembolism may occur when this drug is used together with dabrafenib.
  • Hyperglycemia may occur if mekinist is used together with dabrafenib and with dabrafenib as a single agent.
  • Serious skin toxicity may occur when this medicine is given as a single agent or when used together with dabrafenib.
  • Uveitis and iritis may occur when this drug is used together with dabrafenib and with dabrafenib as a single agent. 


Comments

  1. MATINA13 August 2021 at 23:03

    I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
    liver already present. I started on antiviral medications which
    reduced the viral load initially. After a couple of years the virus
    became resistant. I started on HEPATITIS B Herbal treatment from
    ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
    treatment totally reversed the virus. I did another blood test after
    the 6 months long treatment and tested negative to the virus. Amazing
    treatment! This treatment is a breakthrough for all HBV carriers.

    ReplyDelete

Post a Comment

Popular posts from this blog

Buy Trodelvy sacituzumab govitecan-hziy in India

  Trodelvy Overview: Trodelvy is widely prescribed by Oncologists for the treatment of patients with HR+/HER2- Metastatic Breast Cancer, Metastatic Triple-Negative Breast Cancer (mTNBC), and Metastatic Urothelial Cancer (mUC). It is considered a promising treatment option for those who are not ideal candidates for some conventional therapies. Developed by Immunomedics, Trodelvy 180 mg and Trodelvy 200 mg are two available commercial strengths. Worldwide, Trodelvy is promoted and facilitated by Gilead Sciences. Trodelvy is first approved on 22 April 2020. It is given by intravenous (IV) infusion by a health specialist. The medication received its (European Medicines Agency) EMA approval in October 2021. Trodelvy 180 mg and 200 mg injections are yet to be approved in India. The cost of Trodelvy in India usually depends on international factors. Buy Trodelvy from a Reliable Source: Many suppliers who are not authorized to handle or supply life-saving medicines such as Trodelvy found to b
Read more

What is Non-Small Cell Lung Cancer? What are the stages of NSCLC?

Image
NSCLC, the most common form of lung cancer. It occurs when the healthy cells in the lung change and start growing in an abnormal way, forming a specific mass addressed as tumor, lesion, or nodule. A tumor may develop anywhere in the lung and could be cancerous or benign. A cancerous tumor mainly is malignant, means, it has potential in order to spread to the rest part of the body. A benign tumor is the tumor that can grow but can not spread.  Non-Small Cell Lung Cancer (NSCLC) occurs in the epithelial cells. Doctors can also describe this form of Cancer (NSCLC) based on the type of the epithelial cell where the cancer usually starts.  Adenocarcinoma starts in cells that produce mucus.  Squamous carcinoma basically developed in the cells that line the airways.  Large cell carcinoma usually begins in the cells other than the two types which are described above.  It’s necessary for healthcare providers to distinguish between lung cancer that begins in the squamous cells from lung cancer
Read more

Trodelvy: All about the drug

Image
Indication and Usage The medicine Trodelvy is a Trop-2-directed antibody and topoisomerase inhibitor conjugate drug, which is used in the treatment of adults suffering from locally advanced or metastatic triple-negative breast (mTNBC) cancer, HR+/HER2- metastatic breast cancer, and locally advanced or metastatic urothelial cancer (mUC). It is used when it is not possible to remove cancer with surgery. Trodelvy  comes in the form of single-dose vials in 180 mg for intravenous infusion. Dosage Its dosage is based on body weight, and the recommended dosage is 10 mg/kg administered intravenously once weekly on the first day and eighth day of a repeating 21-day cycle. Administration First infusion: The drug is infused in the body for 3 hours, and during the infusion, the patient is observed for any adverse reaction caused by the infusion. After 30 minutes of infusion, observation should be done again to check for any post-infusion reaction. Subsequent Infusion: If the drug is tolerated in t
Read more